Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting

References

• Anversa P., Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998; 83: 1–14
   PubMed Web of Science ®Google Scholar
• Beltrami A. P., Barlucchi L., Torella D., Baker M., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763–6
   PubMed Web of Science ®Google Scholar
• Henning R. J., Burgos J. D., Ondrovic L., Sanberg P., et al. Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 2006; 15: 647–58
   PubMed Web of Science ®Google Scholar
• Ince H., Petzsch M., Kleine H. D., Eckard H., et al. Prevention of left ventricular remodelling with granulocyte colony‐stimulating factor after acute myocardial infarction: Final 1‐year results of the Front‐Integrated Revascularisation and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granylocyte Colony‐Stimulating Factor (FIRSTLINE‐AMI) Trial. Circulation 2005; 112((9 Suppl))I73–I80
   Google Scholar
• Orlic D., Kajstura J., Chimenti S., Limana F., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci 2001; 98: 10344–9
   PubMed Web of Science ®Google Scholar
• Perin E. C., Dohmann H. F., Borojevic R., Silva S. A., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003; 107: 2294–2302
   PubMed Web of Science ®Google Scholar
• Stamm C., Kleine H. D., Choi Y. H., Dunkelmann S., et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007; 133: 717–25
   PubMed Web of Science ®Google Scholar
• Wollert K. C., Drexler H. Mesenchymal stem cells for myocardial infarction: promises and pitfalls. Circulation 2005; 112: 151–3
   Google Scholar
• Schachinger V., Assmus B., Britten M. B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one‐year results of the TOPCARE‐AMI Trial. J Am Coll Cardiol 2004; 44: 1690–9
   PubMed Web of Science ®Google Scholar
• Stamm C., Westphal B., Kleine H. D., Petzsch M., et al. Autologous bone marrow stem cell transplantation for myocardial regeneration after myocardial infarction. Lancet 2003; 361: 45–6
   PubMed Web of Science ®Google Scholar
• Tse H. F., Thambar S., Kwong Y. L., Rowlings P., et al. Safety of catheter‐based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. Am J Cardiol 2006; 98: 60–2
   PubMedGoogle Scholar
• Menasche P., Hagege A. A., Vilquin J. T., Desnos M., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078–83
   PubMed Web of Science ®Google Scholar
• Lee R. J., Springer M. L., Blanco‐Bose W. E., Shaw R., et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000; 102: 898–901
   PubMed Web of Science ®Google Scholar
• Yoon Y. S., Park J. S., Tkebuchava T., Luedeman C., et al. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 2004; 109: 3154–7
   PubMed Web of Science ®Google Scholar
• Orlic D., Kajstura J., Chimenti S., et al. Nature 2001; 410: 701–5
   PubMed Web of Science ®Google Scholar
• Assmus B., Honold J., Schächinger V., et al. Transcoronary Transplantation of Progenitor Cells in Patients with Persistent Left Ventricular Dysfunction after Myocardial Infarction: A Randomized Controlled Trial (TOPCARE‐CHD). Circulation 2005; 112((Suppl II))II–632
   Google Scholar
• Fischer‐Rasokat U., Assmus B., Honold J., et al. Selective Intracoronary Infusion Of Bone Marrow‐derived Progenitor Cells In Patients With Non‐ischemic Dilated Cardiomyopathy: Initial Results Of The TOPCARE‐DCM Trial. Circulation 2005; 112((Suppl II))II–580
   Google Scholar
• Zeiher A. Bone marrow mononuclear cells for nonischemic myocardial disease., Program and abstracts from the Second International Conference on Cell Therapy for Cardiovascular Diseases; New York, NY, January 19–21, 2006
   Google Scholar
• Fernández‐Avilés F. The Valladolid intracoronary bone marrow experience., Program and abstracts from the Second International Conference on Cell Therapy for Cardiovascular Diseases; New York, NY, January 19–21, 2006
   Google Scholar
• Amado L. C., Saliaris A. P., Schuleri K. H., St John M., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci 2005; 102: 11474–9
   PubMed Web of Science ®Google Scholar
• Hare J. M. Mesenchymal cells in acute MI: promise and potential., Program and abstracts from the Second International Conference on Cell Therapy for Cardiovascular Diseases; New York, NY, January 19–21, 2006
   Google Scholar
• Patel A. N., Geffner L., Vina R. F., Saslavsky J., et al. Surgical treatment of congestive heart failure with autologous stem cell transplantation: a prospective randomized study. J Thorac Cardiovasc Surg 2005; 130: 1631–8
   PubMed Web of Science ®Google Scholar
• Fuchs S., Satler L. F., Kornowski R., Okubagzi P., et al. Catheter‐based autologous bone marrow myocardial injection in no‐option patients with advanced coronary artery disease‐A feasibility study. J Am Coll Cardiol 2003; 41: 1721–4
   PubMed Web of Science ®Google Scholar
• Tse H. F., Kwong Y. L., Chan J. K., Lo G., et al. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003; 361: 47–9
   PubMed Web of Science ®Google Scholar